Low‐level laser therapy vs placebo
- Electrotherapy modalities for adhesive capsulitis (frozen shoulder) 2014 · Cochrane Headline outcomes onlyno estimate extracted1 study · 40 participantsLow
The review found no eligible studies for this question.
It is very uncertain whether TACE followed by 3‐DCRT changes non‐serious adverse events: leukopenia compared with TACE (very low certainty).
It is very uncertain whether low‐frequency electroacupuncture changes adverse eventsc compared with physical exercise or no intervention (very low certainty).
Alginate dressing followed by hydrocolloid dressing showed no clear difference in adverse events compared with hydrocolloid dressing alone (low certainty).
It is very uncertain whether summary of findings table ‐ High flow nasal cannula (HFNC) changes adverse events ‐ nasal trauma compared with continuous positive airway pressure (CPAP) (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether TACE followed by 3‐DCRT changes non‐serious adverse events: total bilirubin elevation compared with TACE (very low certainty).
Low‐dose colchicine showed no clear difference in total adverse events compared with placebo (low certainty).
It is very uncertain whether TACE followed by 3‐DCRT changes non‐serious adverse events: serum transaminases elevation compared with TACE (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether summary of findings table ‐ High flow nasal cannula (HFNC) changes adverse events ‐ abdominal overdistention compared with continuous positive airway pressure (CPAP) (very low certainty).
Low dose naldemedine showed no clear difference in serious adverse eventsg compared with higher doses (low certainty).
Lower BP target may leads to higher other serious adverse events compared with standard BP target (low certainty).
Autologous blood or PRP showed no clear difference in adverse events (pain and swelling at injection site and limitation… compared with placebo at 3 months' follow‐up (low certainty).